---
title: "Sunwah Kingsway Reports Annual Financial Loss Amid Revenue Decline"
description: "Sunwah Kingsway Capital Holdings Limited (HK:0188) reported an annual financial loss of HK$36.4 million for the year ending June 30, 2025, despite a revenue decline to HK$48.7 million from HK$51 milli"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/258889523.md"
published_at: "2025-09-25T12:38:16.000Z"
---

# Sunwah Kingsway Reports Annual Financial Loss Amid Revenue Decline

> Sunwah Kingsway Capital Holdings Limited (HK:0188) reported an annual financial loss of HK$36.4 million for the year ending June 30, 2025, despite a revenue decline to HK$48.7 million from HK$51 million. The loss was attributed to high administrative expenses and fair value changes on investment properties. The latest analyst rating for the stock is a Hold with a price target of HK$0.50. The company operates in the financial services sector, focusing on various income streams and investment solutions.

The latest announcement is out from Sunwah Kingsway Capital Holdings Limited ( (HK:0188) ).

Sunwah Kingsway Capital Holdings Limited reported its annual financial results for the year ending June 30, 2025, revealing a decrease in revenue to HK$48.7 million from HK$51 million in the previous year. Despite a net gain on financial assets, the company faced a loss of HK$36.4 million, attributed to high administrative expenses and fair value changes on investment properties, reflecting ongoing challenges in maintaining profitability.

The most recent analyst rating on (HK:0188) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Sunwah Kingsway Capital Holdings Limited stock, see the HK:0188 Stock Forecast page.

**More about Sunwah Kingsway Capital Holdings Limited**

Sunwah Kingsway Capital Holdings Limited operates in the financial services industry, offering a range of products including commission and fee income, interest income from financial assets and debt securities, dividend income, and rental income. The company is focused on providing financial solutions and investment opportunities.

**Average Trading Volume:** 617,537

**Technical Sentiment Signal:** Buy

**Current Market Cap:** HK$216.7M

### Related Stocks

- [00188.HK - SUNWAH KINGSWAY](https://longbridge.com/en/quote/00188.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Sunwah Kingsway Capital Raises Share Capital With (X) New Shares Issued at (HK$Y) Each | Sunwah Kingsway Capital Holdings Ltd. has announced a capital raise through the issuance of new shares, as detailed in a | [Link](https://longbridge.com/en/news/273342549.md) |
| Sunwah Kingsway Sells 30% Stake in KCG Capital for HK$16.1 Million | Sunwah Kingsway Capital Group Limited will sell a 30% stake in KCG Capital, amounting to 15,000 shares, to an associate  | [Link](https://longbridge.com/en/news/263701813.md) |
| Sunwah Kingsway Capital Holdings Ltd. Announces Upcoming Board Meeting to Approve Annual Results and Final Dividend Decision | Sunwah Kingsway Capital Holdings Ltd. will hold a board meeting on September 25, 2025, to approve its annual results for | [Link](https://longbridge.com/en/news/256878315.md) |
| Yue Da International Delays Factoring Deal Circular After Securing Listing Rules Waiver | Yue Da International Holdings Limited has announced a delay in sending a shareholder circular regarding six factoring ag | [Link](https://longbridge.com/en/news/275906694.md) |
| CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | CSPC Pharmaceutical says ropivacaine long-acting injection approved for clinical trials in China | [Link](https://longbridge.com/en/news/276051793.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.